US › Healthcare

Merit Medical Systems Inc (MMSI)

US · Healthcare · Medical Instruments & Supplies

$85.82+0.34%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$418.8M

Revenue YoY

+9.7%

Net profit

$38.8M

Profit YoY

+19.1%

EPS

$1.09

EPS estimate

$0.85

Net margin

9.3%

EPS came in at 1.09 against a street estimate of 0.85 — a beat of 28.2%.

Key statistics

Market cap

$5.08B

P/E

35.0

Forward P/E

21.6

P/B

3.02

Book value

$27.27

EPS (TTM)

$2.43

52-week high

$94.75

52-week low

$59.74

50-day MA

$69.66

200-day MA

$76.01

Beta

0.51

Analyst view

Analysts rate Merit Medical Systems Inc a buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $99.82.

Shareholding

Insiders

2.48%

Institutions

104.78%

Largest institutional holders

Fund	Stake
BlackRock Inc	14.80%
Vanguard Portfolio Management, LLC	5.90%
Vanguard Capital Management, LLC	4.45%
State Street Corp	3.95%
Fuller & Thaler Asset Management Inc	3.54%
Conestoga Capital Advisors, LLC	3.32%
Geode Capital Management, LLC	2.53%
Morgan Stanley - Brokerage Accounts	2.11%

Recent filings & reports

Document	Date
Quarterly report · Q2 2026	2026-07-30
Results announced · Q3 2026	2026-07-30
Board / officer change · Q2 2026	2026-05-19
Quarterly report · Q1 2026	2026-04-30
Results announced · Q2 2026	2026-04-30
Reg FD disclosure · Q2 2026	2026-04-13
Proxy statement · Q2 2026	2026-03-31
Annual report FY2025	2026-02-24

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Merit Medical Systems Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.